Lilly’s 340B Contract Pharmacy Ban Has Crept Into In-House Pharmacies

Note from the Publisher and CEO Ted Slafsky: I want to acknowledge this date, Sept. 11, and its solemn importance to our country. We honor those who were lost 19 years ago today and continue to cherish the great work of

Read More »

Health Centers Are Preparing to Sue Over Drug Makers' 340B Actions

Health Centers Are Preparing to Sue Over Drug Makers’ 340B Actions

The National Association of Community Health Centers (NACHC) “is preparing legal action” in response to drug manufacturers’ recent unilateral moves to stop providing reduced 340B pricing on their products

Read More »

Breaking News

BREAKING: House Democratic Committee Chairs Say Drug Companies’ Actions Could Put 340B on “Treacherous Path”

House Democratic Committee Chairs Say Drug Companies’ Actions Could Put 340B on “Treacherous Path”

Letting drug manufacturers “pick and choose” which 340B program requirements they will comply with “could set us on a treacherous path where program participants might disregard

Read More »

Breaking News

BREAKING: HRSA is Investigating Whether Manufacturer Policies to Restrict 340B Pricing at Contract Pharmacies Violates Statute

HRSA is Investigating Whether Manufacturer Policies to Restrict 340B Pricing at Contract Pharmacies Violates Statute

In a major development, the Health Resources and Services Administration (HRSA) has told 340B Report that it is investigating whether recent manufacturer policies to restrict

Read More »

Breaking News

BREAKING: Eli Lilly Comment on Today's Actions

After publication, 340B Report received the following comment from Eli Lilly and Co. on its actions that we reported on today:

Report after report shows 340B is not working for patients and needs reform. We support recent executive action on

Read More »

Eli Lilly Dramatically Escalates Efforts to Restrict Access to 340B Pricing


Note from the Publisher and CEO Ted Slafsky:  Bronwyn Mixter is filling in for Tom Mirga this week.  If you have story ideas or tips, feel free to reach her at bronwyn.mixter@340breport.com or 703-403-5926. We’re pleased to include

Read More »

Drug Store Chains Want HHS to Block Pharma’s Moves Against 340B Contract Pharmacy

Note from the Publisher and CEO:  Happy Wednesday.  Bronwyn Mixter is filling in for Tom Mirga this week and next week.  If you have story ideas or tips, feel free to reach her at bronwyn.mixter@340breport.com or 703-403-5926.

Read More »

Breaking News

BREAKING: Kalderos Wants to Give Drug Manufacturers a Way to Pay 340B Rebates in Lieu of Discounts

Kalderos Wants to Give Drug Manufacturers a Way to Pay 340B Rebates in Lieu of Discounts

Prescription drug information technology company Kalderos announced today it is launching a platform called 340B Pay on Sept. 8 “to facilitate 340B discounts

Read More »

340B Supply Chain Partners Push Back Against Manufacturer Contract Pharmacy Requests

Note from Publisher and CEO Ted Slafsky: We are pleased that Bronwyn Mixter is filling in for Tom Mirga for the next two weeks while Tom takes a late summer break. Bronwyn is a veteran health care reporter who covered

Read More »

Breaking News

BREAKING: Novartis the Latest to Seek 340B Contract Pharmacy Claims Data

A Message from Publisher and CEO Ted Slafsky: I hope all is well. For now, we have more requests for 340B Report sponsorships than space available. Fortunately, we are creating a new website and newsletter platform that will accommodate our growing

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live